NO20030201D0 - Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner - Google Patents

Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner

Info

Publication number
NO20030201D0
NO20030201D0 NO20030201A NO20030201A NO20030201D0 NO 20030201 D0 NO20030201 D0 NO 20030201D0 NO 20030201 A NO20030201 A NO 20030201A NO 20030201 A NO20030201 A NO 20030201A NO 20030201 D0 NO20030201 D0 NO 20030201D0
Authority
NO
Norway
Prior art keywords
treatment
receptor antagonists
viral infections
infections
viral
Prior art date
Application number
NO20030201A
Other languages
English (en)
Other versions
NO20030201L (no
Inventor
Susan B Dillon
Ruth Talsinger
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20030201D0 publication Critical patent/NO20030201D0/no
Publication of NO20030201L publication Critical patent/NO20030201L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20030201A 2000-07-18 2003-01-15 Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner NO20030201L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21905300P 2000-07-18 2000-07-18
PCT/US2001/022328 WO2002005814A1 (en) 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections

Publications (2)

Publication Number Publication Date
NO20030201D0 true NO20030201D0 (no) 2003-01-15
NO20030201L NO20030201L (no) 2003-03-17

Family

ID=22817645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030201A NO20030201L (no) 2000-07-18 2003-01-15 Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner

Country Status (17)

Country Link
EP (1) EP1307190A4 (no)
JP (1) JP2004509852A (no)
KR (1) KR20030019587A (no)
CN (1) CN1449285A (no)
AR (1) AR033830A1 (no)
AU (1) AU2001273497A1 (no)
BR (1) BR0112603A (no)
CA (1) CA2418162A1 (no)
CZ (1) CZ2003132A3 (no)
HU (1) HUP0300754A3 (no)
IL (1) IL153921A0 (no)
MX (1) MXPA03000500A (no)
NO (1) NO20030201L (no)
NZ (1) NZ523659A (no)
PL (1) PL365886A1 (no)
WO (1) WO2002005814A1 (no)
ZA (1) ZA200300474B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007001561A (es) * 2004-08-04 2007-04-16 Schering Corp Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas.
WO2015173701A2 (en) * 2014-05-12 2015-11-19 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions for treating infectious diseases
EP3884932A1 (en) * 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
US20230141355A1 (en) * 2020-03-26 2023-05-11 Dompe' Farmaceutici Spa Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) * 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
WO1996005836A2 (en) * 1994-08-25 1996-02-29 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
WO1996025157A1 (en) * 1995-02-17 1996-08-22 Smithkline Beecham Corporation Il-8 receptor antagonists
SE9802729D0 (sv) * 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
SE9802937D0 (sv) * 1998-09-01 1998-09-01 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
HUP0300754A3 (en) 2009-03-02
AR033830A1 (es) 2004-01-07
KR20030019587A (ko) 2003-03-06
HUP0300754A2 (hu) 2003-08-28
AU2001273497A1 (en) 2002-01-30
BR0112603A (pt) 2004-08-24
MXPA03000500A (es) 2003-06-24
NZ523659A (en) 2006-01-27
PL365886A1 (en) 2005-01-10
EP1307190A4 (en) 2007-08-22
EP1307190A1 (en) 2003-05-07
CZ2003132A3 (cs) 2003-09-17
NO20030201L (no) 2003-03-17
ZA200300474B (en) 2004-08-17
CN1449285A (zh) 2003-10-15
CA2418162A1 (en) 2002-01-24
IL153921A0 (en) 2003-07-31
JP2004509852A (ja) 2004-04-02
WO2002005814A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DE60143422D1 (de) Verbinder
DE60026949D1 (de) Verbinder
DE60124863D1 (de) Gegen menschliche interleukin-1-beta gerichtete rekombinante antikörper
DK1604680T3 (da) Anvendelse af butulinumtoksin ved behandlingen af neuralgisk smerte
ID30590A (id) Celana sekali pakai jenis-celana pendek
DE50112057D1 (de) Reinigungsfreundlicher Glaskeramikkörper
EE200200400A (et) Kortikotropiini vabastava faktori antagonistid
DE60102506D1 (de) Verbinder
DE60211241D1 (de) Zusammengesetzte Damenbinde
ATE342323T1 (de) Integriertes hydroisomerizierungs- und alkylierungsverfahren
DK1373256T3 (da) CCR5-antagonister, der er nyttige til behandling af AIDS
DE60116491D1 (de) Wabenartige struktur
AR027945A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
NO20030239L (no) Modifisert virus
DK1458399T3 (da) Pregnansteroider til brug i behandlingen af CNS-sygdomme
DE60119875D1 (de) Verbinder
DE60109670D1 (de) Verbinder
DE60112673D1 (de) Verbinder
DK1345598T3 (da) Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser
DE60107134D1 (de) Verbinder
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
NO20030201D0 (no) Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner
DE60100973D1 (de) Verbinder
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application